全文获取类型
收费全文 | 1620篇 |
免费 | 113篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 60篇 |
妇产科学 | 34篇 |
基础医学 | 252篇 |
口腔科学 | 27篇 |
临床医学 | 289篇 |
内科学 | 314篇 |
皮肤病学 | 4篇 |
神经病学 | 178篇 |
特种医学 | 42篇 |
外科学 | 165篇 |
综合类 | 1篇 |
预防医学 | 181篇 |
眼科学 | 14篇 |
药学 | 124篇 |
肿瘤学 | 41篇 |
出版年
2023年 | 9篇 |
2022年 | 15篇 |
2021年 | 24篇 |
2020年 | 23篇 |
2019年 | 26篇 |
2018年 | 23篇 |
2017年 | 20篇 |
2016年 | 34篇 |
2015年 | 39篇 |
2014年 | 36篇 |
2013年 | 55篇 |
2012年 | 91篇 |
2011年 | 94篇 |
2010年 | 56篇 |
2009年 | 40篇 |
2008年 | 98篇 |
2007年 | 84篇 |
2006年 | 85篇 |
2005年 | 84篇 |
2004年 | 95篇 |
2003年 | 101篇 |
2002年 | 103篇 |
2001年 | 42篇 |
2000年 | 49篇 |
1999年 | 38篇 |
1998年 | 28篇 |
1997年 | 17篇 |
1996年 | 17篇 |
1995年 | 8篇 |
1994年 | 10篇 |
1993年 | 17篇 |
1992年 | 40篇 |
1991年 | 30篇 |
1990年 | 21篇 |
1989年 | 16篇 |
1988年 | 8篇 |
1987年 | 12篇 |
1985年 | 10篇 |
1984年 | 11篇 |
1983年 | 6篇 |
1982年 | 11篇 |
1981年 | 6篇 |
1979年 | 8篇 |
1978年 | 10篇 |
1976年 | 10篇 |
1975年 | 6篇 |
1972年 | 5篇 |
1968年 | 7篇 |
1967年 | 5篇 |
1965年 | 6篇 |
排序方式: 共有1734条查询结果,搜索用时 0 毫秒
81.
The necessity for postoperative inhaled nitric oxide (NO) therapy and predictive factors for that need were retrospectively analysed in 457 paediatric patients at risk of pulmonary hypertensive events following open-heart surgery for congenital heart disease. Inhaled NO was given postoperatively to 46% of the study group and to 23% of all patients undergoing open-heart surgery during the study period. Factors associated with increased need for postoperative NO were age <1 year, Down's syndrome, preoperative pulmonary hypertension and increased pulmonary vascular resistance. Using a multivariate model based on these factors, 73% of the patients who were given NO were identified. Thus, in a setting with unrestricted access to NO therapy, almost half of the patients with cardiac lesions that commonly give rise to postoperative pulmonary hypertension were given postoperative NO. Seventy-three percent of postoperative NO treatment was associated with a relatively small number of pre- and perioperative patient-related risk factors. 相似文献
82.
Sue-Chu M Karjalainen EM Laitinen A Larsson L Laitinen LA Bjermer L 《Respiration; international review of thoracic diseases》2000,67(4):417-425
BACKGROUND: Asthma-like symptoms, methacholine hyperresponsiveness, use of inhaled steroids, airway inflammation, and increased tenascin expression in the reticular basement membrane have been reported in competitive cross-country skiers. OBJECTIVE: To investigate the effect of inhaled budesonide, 400 mug twice daily, on indices of airway inflammation in 'ski asthma', defined as asthma-like symptoms within the previous year and bronchial hyperresponsiveness to methacholine. METHODS: A randomised double-blind placebo-controlled parallel-group bronchial biopsy and bronchoalveolar lavage (BAL) study of 25 (19 male) competitive cross-country skiers (mean age 18 (16-20) years for a mean (range) treatment period of 22 (10-32) weeks over the competitive season. RESULTS: No changes were seen regarding cellular inflammation in the bronchial mucosa or tenascin expression. In the BAL fluid, both groups had a significant decrease in activated T-suppressor (CD8) lymphocytes and an increase in macrophages, with no differences across the groups. Within the budesonide group, there was a decrease in IL2 receptor-activated T-helper lymphocytes and an improvement in FEV(1). Asthma-like symptoms were unchanged in 17 (68%) skiers. Methacholine provocation test was negative in 15 subjects, and remained positive in 5 subjects in each group. The improvement in bronchial responsiveness occurred in both groups and was not accompanied by a decrease in cellular inflammation. CONCLUSIONS: We were unable to show any clear beneficial effect of budesonide in 'ski asthma'. As changes in training intensity probably accounted for the spontaneous improvement in bronchial responsiveness, more attention should be directed at reducing environmental stress to the airways than at attempting pharmacological modulation of induced inflammatory changes. 相似文献
83.
84.
85.
R Rimón P Halonen P Puhakka L Laitinen R Marttila L Salmela 《The Journal of clinical psychiatry》1979,40(5):241-243
Serum and CSF specimens from 16 schizophrenic patients and 18 nonpsychiatric controls were tested by radioimmunoassay for immunoglobulin G antibody of capsid, envelope and excreted antigens of herpes simplex type 1 virus. There were no significant differences in the antibody levels between the schizophrenic patients and the controls. The etiological role of viruses and virus-like agents in schizophrenia and some methodological aspects are discussed. 相似文献
86.
Laitinen K Arvola T Moilanen E Lampi AM Ruuska T Isolauri E 《Biology of the neonate》2005,87(1):66-72
OBJECTIVE: The aim of this study was to ascertain factors that might be protective of the appearance of gross blood in the stools of breast-fed infants. METHODS: Logistic regression models were formed to search for variables possibly explaining the condition. In addition to the analyzed breast milk factors, mother's allergic disease was introduced into the models to control for its possible confounding effect. The breast milk samples, collected from mothers of infants with gross blood in stools (n = 23) and from mothers of healthy age-matched infants (n = 71), were analyzed for concentrations of transforming growth factor-beta2, tumor necrosis factor-alpha, interleukin (IL)-4, IL-10, prostaglandin (PG)E2, cysteinyl leukotrienes (Cys-LTs) and fatty acid composition. RESULTS AND CONCLUSIONS: Increase in the concentrations of PGE2 and Cys-LTs in the breast milk together with mother's allergic disease reduced the likelihood of gross blood in stools in the breast-fed infant. The results suggest that no single factor, but a combination of immunomodulatory factors may protect the child from gross blood in the stools of breast-fed infants. Allergic disease was not a risk factor as mother's allergic disease appeared to counterbalance the gross blood in stools. Due to the preliminary nature of the study, the results need to be verified in a larger setting. The challenge for the future lies in identifying of such active compounds for dietary modification to enforce particularly the properties of the breast milk which are immunoprotective for the infant and to reduce the likelihood of intestinal disorders in at risk infants. 相似文献
87.
88.
Tani P Lindberg N Nieminen-von Wendt T von Wendt L Alanko L Appelberg B Porkka-Heiskanen T 《Psychiatry and clinical neurosciences》2005,59(2):206-208
A high prevalence of subjective insomnia in adults with Asperger syndrome has been reported. In the present study the sleep quality of these patients was studied using wrist actigraphy. Nineteen adults with Asperger syndrome and frequent feelings of insomnia were compared with 10 controls devoid of neuropsychiatric disorders and subjective sleep problems during six consecutive nights. The patients had similar actigraphic sleep profile to the controls. The subjective low sleep quality in patients was not reflected in actigraphic assessment of sleep. This finding suggests that pervasive anxiety inherent in persons with Asperger syndrome predisposes them to insomnia complaints. 相似文献
89.
Bilateral subthalamic nucleus stimulation improves health-related quality of life in Parkinsonian patients 总被引:5,自引:0,他引:5
Erola T Karinen P Heikkinen E Tuominen J Haapaniemi T Koivukangas J Myllylä V 《Parkinsonism & related disorders》2005,11(2):89-94
Parkinson's disease (PD) is a common neurological disorder. Recently, bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) has become an option in the treatment of severe PD. We measured the health-related quality of life (HRQoL) of 27 parkinsonian patients, who underwent a bilateral STN-operation. The instruments used for the evaluation of the HRQoL were the Parkinson's Disease Questionnaire (PDQ-39) and the Finnish version of the Nottingham Health Profile (NHP). We found that the quality of life significantly improved when measured with both HRQoL scales. Clinical improvement and improvement in HRQoL were positively correlated. 相似文献
90.
Isolauri E Ouwehand AC Laitinen K 《Acta paediatrica (Oslo, Norway : 1992). Supplement》2005,94(449):110-114
The increased prevalence of atopic diseases, i.e. atopic eczema, allergic rhinitis and asthma, has been described as the epidemic of the 21st century in Western societies. New approaches in the fight against allergic diseases are clearly called for, the target being the persistence of the allergic responder pattern beyond infancy. The advantage afforded by elimination diets lies in the silencing of specific allergic inflammation induced by an offending food. Novel nutritional approaches, beyond the treatment of food allergies, have recently attracted research interest subsequent to the identification of the immunomodulatory potential of specific dietary compounds. Dietary lipids as immunomodulators may prevent allergic sensitization by down-regulating inflammatory response whilst protecting the epithelial barrier. Probiotic bacteria have been shown to reinforce the different lines of gut defence: immune exclusion, immune elimination and immune regulation. On this basis, the strategy against allergic disease proposed here is based on the administration of tolerogenic gut-processed peptide fragments of a specific protein, in addition to the use of specific dietary compounds such as fatty acids and antioxidants, and introducing a microbial stimulus for the immature immune system by means of cultures of beneficial live micro-organisms characteristic of the healthy infant gut microbiota. 相似文献